Skip to main content

Table 2 Microbial documentation of infectious events in ICU patients with severe COVID-19

From: Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect

Microbiological documentation Community-acquired infections Early hospital-acquired infections Late hospital-acquired infections
Bacterial pneumonia
 Acinetobacter baumannii, n (%) 0 (0) 1 (3) 0 (0)
 Citrobacter koseri, n (%) 0 (0) 1 (3) 1 (3)
 Escherichia coli, n (%) 0 (0) 0 (0) 1 (3)
 Haemophilus influenzae, n (%) 1 (3) 4 (11) 0 (0)
 Klebsiella sp., n (%) 1 (3) 3 (8) 1 (3)
 Moraxella catarrhalis, n (%) 0 (0) 1 (3) 0 (0)
 Morganella morganii, n (%) 0 (0) 0 (0) 1 (3)
 Pseudomonas aeruginosa, n (%) 1 (3) 2 (6) 5 (14)
 Serratia sp., n (%) 1 (3) 0 (0) 1 (3)
 Staphylococcus aureus, n (%) 1 (3) 2 (6) 4 (11)
 Stenotrophomonas maltophila, n (%) 1 (3) 0 (0) 1 (3)
 Streptococcus constellatus, n (%) 0 (0) 0 (0) 1 (3)
Bacteremia
 Corynebacterium sp., n (%) 1 (3) 0 (0) 0 (0)
 Enterococcus faecalis, n (%) 0 (0) 0 (0) 1 (3)
 Klebsiella pneumoniae, n (%) 0 (0) 0 (0) 1 (3)
 Pseudomonas aeruginosa, n (%) 0 (0) 0 (0) 1 (3)
 Streptococcus mitis, n (%) 0 (0) 0 (0) 1 (3)
Fungal pneumoniaa
 Aspergillus fumigatus, n (%) 1 (3) 0 (0) 2 (6)
Fungemiaa
 Candida albicans, n (%) 0 (0) 0 (0) 2 (6)
  1. aAll fungal events are reported in the table, while only first bacterial events are given in the table